Bird Flu Update as Antibody Therapy May Prevent Severe Illness
"This type of prevention can be very useful in controlling infection outbreaks and containing the bird flu pandemic," said an immunologist.
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Pursuant to the transaction with Telix, ImaginAb has retained its lead imaging candidate, CD8 ImmunoPET, which is currently in Phase 2 clinical trials and has been licensed by numerous pharmaceutical ...
Protein labeling of tens of millions of densely packed cells in organ-scale tissues
Tissue processing advance can label proteins at the level of individual cells across whole, intact rodent brains and other large samples just as fast and uniformly as in dissociated single cells.
ImmunoPrecise Antibodies (IPA) Announces Completion of At-the-Market Equity Offering and Full Conversion of Yorkville Debenture
In addition to the ATM Program completion, IPA has now fully satisfied its outstanding obligations with Yorkville Advisors, as Yorkville has converted all principal amounts under the debenture ...
Sanofi (SNY) Q4 2024 Earnings Call Transcript
Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...
News Medical2d
A deep dive in CAR+ T-cell therapy
In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...
Eledon Pharmaceuticals: At The Forefront Of The Organ Transplant Management Business
Eledon Pharmaceuticals has a promising anti-CD40L antibody for organ rejection prevention in transplantation. Learn more ...
Vincerx Pharma, Inc. and Oqory, Inc. Highlight Promising Data for Oqory’s TROP2 Antibody Drug Conjugate, OQY-3258
OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...
IFLScience12h
Joint Vaccine Against COVID-19 And Flu Provides Strong Protection In Early Tests
“Although individual vaccines have been developed and approved for use in humans against SARS-CoV-2 and influenza viruses, there is no vaccine approved to simultaneously protect against both viral ...
AZoLifeSciences on MSN2d
Fast and Precise Protein Labeling in Intact Tissues with MIT Technology
A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D ...
eLife2d
mTOR inhibition in Q175 Huntington’s disease model mice facilitates neuronal autophagy and mutant huntingtin clearance
This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...
Healio1d
Tralokinumab demonstrates real-world utility for atopic dermatitis
Data from a retrospective multicenter study, along with a review of previous trials, supported the real-world utility of ...